Xiaoxia Su Selected Research

Xiaoxia Su Research Topics

7	Osteoporosis 01/2023 - 01/2016
3	Neoplasms (Cancer) 08/2023 - 01/2021
3	Colitis 01/2018 - 01/2016
2	Inflammation (Inflammations) 01/2023 - 01/2017
2	Bone Diseases (Bone Disease) 01/2022 - 01/2022
1	Appendicitis 01/2024
1	Coinfection 10/2023
1	Wilms Tumor (Wilm's Tumor) 08/2023
1	Alveolar Bone Loss 01/2023
1	Intussusception 01/2023
1	Bone Resorption 12/2022
1	Echinococcosis (Hydatid Cysts) 01/2022
1	Hepatic Echinococcosis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Periodontitis 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2020
1	Arteriovenous Fistula 10/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Embolism (Embolus) 01/2017
1	Thrombosis (Thrombus) 01/2017

5	Therapeutic UsesIBA 01/2023 - 01/2016
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
2	butaselenIBA 01/2023 - 01/2021
2	Thioredoxin-Disulfide ReductaseIBA 01/2023 - 01/2021
2	Histones (Histone)IBA 01/2022 - 01/2018
2	AntioxidantsIBA 01/2021 - 04/2016
1	C-Reactive ProteinIBA 01/2024
1	Prealbumin (Transthyretin)IBA 01/2024
1	Antiviral Agents (Antivirals)IBA 10/2023
1	DeoxyuridineIBA 08/2023
1	Circular RNAIBA 08/2023
1	2-furoyl-LIGRLO-amideIBA 01/2023
1	SaltsIBA 01/2023
1	hyperosideIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Trifluoroacetic Acid (Trifluoroacetate)IBA 01/2023
1	CateninsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	matrigelIBA 01/2022
1	Nanoparticle Drug Delivery SystemIBA 01/2022
1	Albendazole (Albenza)FDA Link 01/2022
1	SeleniumIBA 01/2021
1	SilymarinIBA 01/2021
1	ThioredoxinsIBA 01/2021
1	CollagenIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Serum AlbuminIBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2018
1	human KAT2A proteinIBA 10/2017
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Estrogens (Estrogen)FDA Link 04/2016
1	MelatoninIBA 01/2016

8	Therapeutics 01/2023 - 01/2016
2	Immunotherapy 01/2023 - 01/2016
1	Enema (Enemas) 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Contraindications 01/2022
1	Hepatectomy 01/2022
1	Liver Transplantation 01/2022
1	Intraperitoneal Injections 01/2021
1	Oral Administration 01/2021
1	Renal Dialysis (Hemodialysis) 10/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017